. Involvement of Ptch1 in Osteoclastogenesis (A) Expression of Ptch1 mRNA during osteoclast differentiation from bone marrow macrophages (BMMfs) and RAW264.7 cells. BMMfs were isolated from mouse bone marrow cells cultured in the presence of M-CSF (10 ng/mL) and further cultured with soluble RANKL (30 ng/mL) and M-CSF (10 ng/mL) for 10 days. RAW264.7 cells were stimulated with soluble RANKL (100 ng/mL) for 3 days. (A) Protein expression of Gli2 in OPs from WT and Ptch1+/-littermates. Cells were cultured for 10 days in a-MEM/10% FBS. Expression was analyzed by immunoblot analysis using specific antibodies.
As described in the data sheet of the Gli2 antibody used in this experiment, full-length Gli2 is observed at the position of 144 kDa (Gli2-144). Processed Gli2 is also observed at 78 kDa (Gli2-78). (B)
Localization of endogenous Gli2 in WT OPs cultured for 10 days in a-MEM/10% FBS. IB, immunoblot; C, cytosol fraction; N, nuclear fraction. and were cultured for 7 days. Endogenous protein expression was analyzed by immunoblot analysis using specific antibodies. Arrows, specific bands; IB, immunoblot. 
Supplemental Experimental Procedures

Genotyping of Mice
The wild type and mutant alleles of Ptch1 or Gli3 were detected by PCR as described (Goodrich et al., 1997; Maynard et al., 2002) . The mutants of Oc-luc were generated by a PCR-based strategy using pfu polymerase (KOD Plus, Toyobo, Tokyo, Japan). To construct plasmids expressing Myc-tagged human GLI3, GLI3 fragments in pCS2-MT vectors were cloned into pShuttle mammalian expression vectors (Clontech). For construction of GLI3rep, C-terminal deletions of GLI3 at the Cla I site (GLI3C'ΔClaI) (Ruiz i Altaba, 1999) were cloned into pShuttle mammalian expression vectors. For construction of HA-tagged GLI1
Plasmid Construction
and Col1a1 2.3 kb Luc, human GLI1 cDNA and 2.3 kb fragment of mouse Col1a1 promoter were isolated by a PCR-based strategy and cloned into pCMV-HA vector (Clontech) and pGL3 reporter vector (Promega), respectively. Adenoviral vectors expressing GLI3 or GLI3rep were constructed with the AdenoX Expression system (Clontech) according to the manufacturer's instructions.
Immunoblotting
The following antibodies were used for immunoblotting: anti-Flag rabbit polyclonal antibody (1:1000;
Sigma-Aldrich), anti-Myc mouse monoclonal antibody (clone 4A6, 1:1000; Upstate, Lake Placid, NY), anti-GLI3 rabbit polyclonal antibody (H-280, 1:100; Santa Cruz Biotechnologies, Santa Cruz, CA), MBL, Nagoya, Japan), anti-Cbfb mouse monoclonal antibody (1:500; MBL), and anti-Actin rabbit antibody (1:1000; Sigma-Aldrich).
EMSA
In Figure 5B , 2 μg of nuclear extracts was added to the binding mixture containing 50 mM KCl, 25 mM HEPES-KOH (pH 7.9), 5 mM MgCl 2 , 10 mM ZnSO 4 , 1 mM DTT, 12% glycerol, 0.1% NP-40, 0.25 μg of Poly d(I-C), 0.1 μg of Poly L-lysine, and 30 fmol of the DIG-labeled probe.
In Figure 5C , 2 μg of nuclear extracts of Runx2-transfected COS-7 cells and 1 (1x), 2 (2x), and 4 (4x) μg of those of GLI3rep-transfected ones were added to the binding mixture containing 50 mM KCl, 25 mM HEPES-KOH (pH 7.9), 5 mM MgCl 2 , 10 mM ZnSO 4 , 1 mM DTT, 12% glycerol, 0.1% NP-40, 0.25 μg of Poly d(I-C), 0.1 μg of Poly L-lysine, and 30 fmol of the DIG-labeled probe.
In Figure 5E , 5 μg of nuclear extracts from mouse primary calvarial cells was added to the binding mixture containing 20 mM HEPES (pH 7.6), 1 mM EDTA, 10 mM (NH 4 ) 2 SO 4, 30 mM KCl, 1 mM DTT, 2% Tween 20, 1 μg of Poly d(I-C), 0.1 μg of Poly L-lysine, and 30 fmol of the DIG-labeled probe. Binding reaction was performed for 20 min at 4 °C, and 130-fold molar excess of unlabeled probes was used for competition. When antibodies were used, nuclear extracts were incubated with 2 μg of anti-PEBP2αA antibodies (M-70, Santa Cruz Biotechnologies) or 2 μg of anti-GLI3 antibodies (H-280, Santa Cruz Biotechnologies) for 20 min at 4 °C prior to binding reaction.
In Supplemental figure S7, 2 μg of nuclear extracts and 0.5 (1x), 1 (2x), and 2 (4x) μl of reticulocyte lysate translation reaction were added to the binding mixture containing 50 mM KCl, 25 mM HEPES-KOH (pH 7.9), 5 mM MgCl 2 , 10 mM ZnSO 4 , 1 mM DTT, 12% glycerol, 0.1% NP-40, 0.25 μg of Poly d(I-C), 0.1 μg of Poly L-lysine, and 30 fmol of the DIG-labeled probe.
Electrophoresis was performed with a 6% TBE gel (Invitrogen, Carlsbad, CA) in 0.25x TBE at 150 V for 85 min and subjected to blotting onto nylon membranes and detection for DIG-labeled probes.
Oligonucleotide probes containing the OSE2 sequence (Ducy et al., 1997) , Gli-binding sequence (Gli-BS) in human PTCH1 promoter (Agren et al., 2004) , and their mutations were as follows: OSE2
wild type, 5'-AGCTGCAATCACCAACCACAGCA-3'; OSE2 mutant 1 for Runx2, 5'-AGCTGCAATCACCAGACACAGCA-3'; OSE2 mutant 2 for Gli3, 5'-AGCTGCAATATATAACCACAGCA-3'; Gli-BS wild type, 5'-TCGAAGAGACCACCCAGGTAGGCAACCCAGT -3'; Gli-BS mutant, 5'-TCGAAGAGACCAGTGGGGTAGGCAAGTGGGT -3'.
In EMSA using LEF1-binding site probes, binding reactions contained 1 μg of nuclear extracts, 10 mM HEPES-KOH (pH 7.9), 50 mM NaCl, 1 mM MgCl 2, 0.5 mM EDTA, 0.5 mM DTT, 4% glycerol, 0.5 μg of Poly d(I-C), 0.1 μg of Poly L-lysine, and 30 fmol of the DIG-labeled probe. Electrophoresis was performed with a 6% TBE gel in 0.25x TBE at 150 V for 85 min. Oligonucleotide probes containing the LEF1-binding sequence and their mutations (Ishitani et al., 1999) were as follows:
wild-type, 5'-GATCTTACCCCCTTTGATCTTACCCCCTTTGATCTTA-3'; mutant, 5'-GGCCTTACCCCCTTTGGCCTTACCCCCTTTGGCCTTA-3'.
In EMSA using 3xCAGA probes, binding reactions contained 1 μg of nuclear extracts, 20 mM HEPES-KOH (pH 7.9), 30 mM KCl, 4 mM MgCl 2, 0.1 mM EDTA 10% glycerol, 0.1 μg of Poly d(I-C), 0.1 μg of Poly L-lysine, and 30 fmol of the DIG-labeled probe. Electrophoresis was performed with a 6% TBE gel in 0.5x TBE at 150 V for 50 min. Oligonucleotide probes containing the CAGA box and their mutations (Dennler et al., 1998) were as follows: wild type, 5'-TCGAGAGCCAGACAAGGAGCCAGACAAGGAGCCAGACAC-3'; mutant, 5'-TCGAGAGCTACACAAGGAGCTACACAAGGAGCTACACAC-3'.
ChIP
ChIP was performed using EZ ChIP (Upstate) according to the manufacturer's instructions. The protein and DNA were cross-linked by the direct addition of formaldehyde to the culture medium at a final concentration of 1% and incubated at 37 °C for 10 min. Cell lysates were sonicated using 
Bone Mineral Density Measurements of NBCCS Patients
Five patients (1 male, 4 females) had been diagnosed as having NBCCS at Chiba University and Saitama Medical School. Of the 4 female patients, 1 patient had amenorrhea due to hypogonadotropic hypogonadism, and 2 patients had late menarche, suggesting that they had ovarian insufficiency. We excluded these 3 patients from the study, because ovarian insufficiency could affect bone metabolism, making it difficult to precisely assess the influence of NBCCS. We measured BMDs of the lumbar spine and femoral neck in the remaining 2 patients (1 male and 1 female) using dual-energy x-ray
